Why is CAMBRIA-1 emerging as AstraZeneca’s key breast cancer catalyst?

Investing.com Gold reports: Why is CAMBRIA-1 emerging as AstraZeneca’s key breast cancer catalyst?. Full body text was unavailable at ingest time, so this brief is based on headline context.